Collaboration between two companies leads to more informed decisions for clinical researchers, grounded in real-world evidence.
Citeline, part of the Informa Pharma Intelligence family, and Clinerion, today announced a partnership between the two companies providing clinical researchers with a more holistic method for making more evidence-based decisions during their clinical trial processes.
The Clinerion and Citeline™ partnership allows clinical teams to overlay the deep clinical data about a patient from Clinerion with the site and investigator data from Citeline’s Sitetrove to make more informed decisions on where to place a study. The result is a more effective evidence-based approach to study feasibility, allowing clinical researchers to better understand which sites have patients that match their criteria, along with the experienced investigators to run the study.
Specifically, using Citeline and Clinerion together, clinical researchers can not only see which experienced clinical investigators have conducted studies at a particular location, but also the number of patients treated at that location matching the patient population and the number of trials the healthcare organization has conducted matching the respective researcher’s protocol. The resulting data can be further turned into a heat map, showing the number of patients located at each healthcare organization.
“We’re always looking for ways to help our clients make better decisions grounded in the current pharma landscape through data and deep domain expertise,” said Jason Tse, VP Business Development at Informa Pharma Intelligence. “Most patient data is focused highly on the U.S. and by partnering with Clinerion we’re able to deliver this incredible resource for researchers around the world, and help them make more evidence-based feasibility decisions in their clinical trial processes.”
“Combined, the offerings of Citeline and Clinerion offer better actionable data intelligence than the sum of their individual parts, creating a fully comprehensive overview pin-pointing where the protocol matching patients are with site and trial performance data,” said Ian Rentsch, Clinerion CEO. “Clinerion’s patient data analytics brings a wealth of real-world data from our global hospital network into play alongside Citeline’s insights into site performance, investigator expertise and trial status. We show where the patients are that match the clinical protocols and treatments. This synergy of services gives users the right tools to make effective decisions around clinical trial feasibility and site identification and ensure success in setting up a trial. Clinerion is all about re-imagining research; in this case, with Citeline, we are re-imagining trial start-up processes to get new drugs and treatments quicker to patients.”
To learn more about the partnership, Citeline and Clinerion are at The SCOPE Summit, February 18-21, 2019 in Orlando FL.
Clinerion: Booth 19 (in the Foyer)
Pharma Intelligence: Booth 408
